Dermatology Drugs
291 FDA-approved drugs
TheraRadar tracks 291 FDA-approved dermatology drugs from 137 companies across 19 drug classes, led by BAUSCH, with 175 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Dermatology.
Dermatology Approvals by Year
5
'15
2
'16
8
'17
7
'18
9
'19
6
'20
3
'21
2
'22
4
'23
3
'24
3
'25
1
'26
Recent Dermatology Drug Approvals
ADQUEY
DIFAMILAST
the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderat...
2026-02-12
ACROTECH BIOPHARMA
ANZUPGO
DELGOCITINIB
the topical treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inad...
2025-07-23
LEO PHARMA AS
JAK1JAK2JAK3
HALOBETASOL PROPIONATE AND TAZAROTENE
HALOBETASOL PROPIONATE
the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses...
2025-05-02
SUN PHARMA CANADA
zevaskyn
Prademagene zamikeracel
wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB)...
2025-04-27
Abeona Therapeutics Inc.
EMROSI
MINOCYCLINE HYDROCHLORIDE
EMROSI is indicated to treat inflammatory lesions (papules and pustules) of rosacea in adults...
2024-11-01
JOURNEY
SOFDRA
SOFPIRONIUM BROMIDE
primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older...
2024-06-18
BOTANIX SB
ZELSUVMI
BERDAZIMER SODIUM
the topical treatment of molluscum contagiosum (MC) in adults and pediatric patients 1 year of age a...
2024-01-05
LNHC
FILSUVEZ
BIRCH TRITERPENES
wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric p...
2023-12-18
CHIESI
CABTREO
ADAPALENE
the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older...
2023-10-20
BAUSCH
YCANTH
CANTHARIDIN
the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and ol...
2023-07-21
VERRICA PHARMS
VYJUVEK
beremagene geperpavec-svdt
wounds in adult and pediatric patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) ...
2023-05-18
Krystal Biotech, Inc.
NEXOBRID
ANACAULASE-BCDB
eschar removal in adults and pediatric patients with deep partial thickness (DPT) and/or full thickn...
2022-12-28
MEDIWOUND, LTD
EPSOLAY
BENZOYL PEROXIDE
inflammatory lesions of rosacea in adults...
2022-04-22
MAYNE PHARMA INC
OXYMETAZOLINE HYDROCHLORIDE
OXYMETAZOLINE HYDROCHLORIDE
Uses temporarily relieves nasal congestion due to: common cold hay fever upper respiratory allergies...
2021-10-04
SUN PHARMA CANADA
TWYNEO
BENZOYL PEROXIDE
the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older...
2021-07-26
MAYNE PHARMA INC
DEOXYCHOLIC ACID
DEOXYCHOLIC ACID
improvement in the appearance of moderate to severe convexity or fullness associated with submental ...
2021-04-02
WILSHIRE PHARMS INC
KLISYRI
TIRBANIBULIN
the topical field treatment of actinic keratosis on the face or scalp...
2020-12-14
ALMIRALL
WINLEVI
CLASCOTERONE
the topical treatment of acne vulgaris in patients 12 years of age and older...
2020-08-26
Sun Pharma
XEGLYZE
ABAMETAPIR
2020-07-24
LNHC
QWO
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES
2020-07-06
ENDO GLOBAL AESTHETICS LTD
Showing the 20 most recent of 291 dermatology drugs. View all 291 →
Top Dermatology Companies
Dermatology Active Trials by Indication
175 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Dermatology Drug Classes
Retinoid 24
Corticosteroid 21
Macrolide 3
Azole Antifungal 3
Nitroimidazole Antimicrobial 3
Cytolytic Agent 2
Nucleoside Metabolic Inhibitor 2
Janus Kinase Inhibitor 1
Microtubule Inhibitor 1
Androgen Receptor Inhibitor 1
Dermatology at a Glance
- Total Drugs
- 291
- Companies
- 137
- Drug Classes
- 19
- Active Trials
- 175
- Latest Approval
- 2026-02-12